(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 4.54%4.17B | 3.22%7.97B | 15.82%3.98B | 28.22%7.72B | 8.79%3.44B | 28.50%6.02B | 72.93%3.16B | 7.92%4.69B | -4.81%1.83B | -15.08%4.34B |
Operating income | 4.54%4.17B | 3.22%7.97B | 15.82%3.98B | 28.22%7.72B | 8.79%3.44B | 28.50%6.02B | 72.93%3.16B | 7.92%4.69B | -4.81%1.83B | -15.08%4.34B |
Cost of sales | ---- | ---- | ---- | ---- | -8.92%-3.27B | -28.04%-5.7B | -69.44%-3B | -6.96%-4.45B | 2.06%-1.77B | 12.71%-4.16B |
Operating expenses | -4.33%-3.97B | -3.76%-7.6B | -16.60%-3.81B | -28.55%-7.32B | -8.92%-3.27B | -28.04%-5.7B | -69.44%-3B | -6.96%-4.45B | 2.06%-1.77B | 12.71%-4.16B |
Gross profit | 9.11%190.87M | -6.71%371.28M | 1.22%174.93M | 22.49%397.98M | 6.44%172.82M | 36.97%324.92M | 179.32%162.37M | 29.87%237.22M | -48.66%58.13M | -47.50%182.67M |
Selling expenses | -6.69%-26.33M | 0.09%-50.95M | -16.68%-24.68M | 5.91%-50.99M | 29.65%-21.15M | -11.67%-54.19M | -20.63%-30.07M | 8.17%-48.53M | 2.79%-24.93M | 37.28%-52.85M |
Administrative expenses | 5.15%-100.18M | 14.85%-214.72M | 24.85%-105.62M | 2.97%-252.16M | -16.51%-140.55M | -26.88%-259.88M | -41.29%-120.63M | 0.34%-204.82M | -3.79%-85.38M | -1.11%-205.53M |
Research and development expenses | 12.47%-12.08M | -101.67%-26.8M | ---13.8M | ---13.29M | ---- | ---- | ---- | ---- | ---- | ---- |
Profit from asset sales | 270.88%653.89K | -26.64%282.78K | --176.31K | --385.46K | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | 311.30%1.98M | 135.60%6.43M | ---935.42K | ---18.05M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 311.30%1.98M | 135.60%6.43M | ---935.42K | ---18.05M | ---- | ---- | ---- | ---- | ---- | ---- |
Operating interest expense | ---- | ---- | ---- | ---- | -35.84%-3.38M | -29.37%-8.14M | 34.72%-2.49M | 25.98%-6.29M | ---3.81M | ---8.5M |
Special items of operating profit | -50.47%4.06M | 41.09%17.46M | -66.69%8.19M | -78.82%12.38M | 48.19%24.58M | 23.09%58.43M | -3.06%16.59M | 1.32%47.47M | -34.09%17.11M | 25.92%46.86M |
Operating profit | 74.42%44.84M | 32.84%71.92M | -20.45%25.71M | -11.46%54.14M | 25.41%32.32M | 144.09%61.15M | 166.28%25.77M | 167.07%25.05M | -224.31%-38.88M | -138.26%-37.35M |
Financing cost | -2,097.97%-2.21M | -73.98%3.23M | --110.37K | --12.39M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | ---- | ---- | ---- | ---- | -6.37%-1.67M | -55.75%-3.56M | 5.02%-1.57M | -782.69%-2.29M | -81.36%-1.65M | -93.14%335K |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | 163.87%1.26M | ---- | 47.83%476K | ---- | -69.68%322K |
Special items of earning before tax | -91.70%689.84K | -107.79%-136.97K | --8.31M | --1.76M | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | 26.95%43.32M | 9.83%75.01M | 11.35%34.12M | 16.06%68.29M | 26.64%30.65M | 153.19%58.84M | 159.70%24.2M | 163.33%23.24M | -250.63%-40.53M | -136.06%-36.7M |
Tax | -103.47%-12.1M | 21.73%-17.05M | -8.04%-5.95M | -30.14%-21.78M | 57.38%-5.51M | -77.06%-16.73M | -1,215.28%-12.92M | -20.55%-9.45M | 114.33%1.16M | 77.83%-7.84M |
After-tax profit from continuing operations | 10.80%31.22M | 24.61%57.96M | 12.08%28.18M | 10.46%46.52M | 122.81%25.14M | 205.36%42.11M | 128.66%11.28M | 130.96%13.79M | -309.12%-39.37M | -167.06%-44.54M |
Earning after tax | 10.80%31.22M | 24.61%57.96M | 12.08%28.18M | 10.46%46.52M | 122.81%25.14M | 205.36%42.11M | 128.66%11.28M | 130.96%13.79M | -309.12%-39.37M | -167.06%-44.54M |
Minority profit | 4,538.78%1.96M | -81.13%1.52M | -99.28%42.23K | -38.02%8.03M | -15.01%5.87M | -3.05%12.96M | 75.23%6.91M | 16.96%13.37M | -18.41%3.94M | -43.71%11.43M |
Profit attributable to shareholders | 4.00%29.26M | 46.68%56.45M | 46.03%28.13M | 32.02%38.48M | 340.67%19.27M | 6,823.52%29.15M | 110.09%4.37M | 100.75%421K | -409.55%-43.32M | -221.38%-55.97M |
Basic earnings per share | 5.88%0.18 | 45.83%0.35 | 41.67%0.17 | 33.33%0.24 | 300.00%0.12 | 0.18 | 111.11%0.03 | 0 | -400.00%-0.27 | -225.00%-0.35 |
Diluted earnings per share | 5.88%0.18 | 45.83%0.35 | 41.67%0.17 | 33.33%0.24 | 300.00%0.12 | 0.18 | 111.11%0.03 | 0 | -400.00%-0.27 | -225.00%-0.35 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Grant Tung Certified Public Accountants (Special General Partnership) | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Daxin Leung Hok Lian (Hong Kong) Certified Public Accountants Limited | -- | Ernst & Young (Special General Partnership), Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data